开始
warrenhochfeld

Dynavax final breakout ahead of PDUFA Heplisav announcement

做多
Dynavax Technologies Corporation (NASDAQ:DVAX)  
warrenhochfeld  
NASDAQ:DVAX   Dynavax Technologies Corporation
Trend Analysis Beyond Technical Analysis
2
0
trendanalysis beyondta
Start of final bull run ahead of 9th November FDA announcement of Heplisav . $28 price projection. Final buy opportunity at $20
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。